EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic dose prediction of α5-GABA receptor modulation from simulated EEG of depression severity

Alexandre Guet-McCreight iD, Frank Mazza, Thomas D Prevot, Etienne Sibille, Etay Hay iD

PLOS Computational Biology · 2024

DOI: 10.1371/journal.pcbi.1012693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von Alexandre Guet-McCreight und 4 weiteren Autor:innen. Beteiligte Einrichtung: Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Canada. Hauptthemen laut MEDLINE: Electroencephalography, Receptors, GABA-A, Major Depressive Disorder. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Krembil Foundation, Labatt Family Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment for major depressive disorder (depression) often has partial efficacy and a large portion of patients are treatment resistant. Recent studies implicate reduced somatostatin (SST) interneuron inhibition in depression, and new pharmacology boosting this inhibition via positive allosteric modulators of α5-GABA A receptors (α5-PAM) offers a promising effective treatment. However, testing the effect of α5-PAM on human brain activity is limited, meriting the use of detailed simulations. We utilized our previous detailed computational models of human depression microcircuits with reduced SST interneuron inhibition and α5-PAM effects, to simulate EEG of individual microcircuits across depression severity and α5-PAM doses. We developed machine learning models that predicted optimal dose from EEG with high accuracy and recovered microcircuit activity and EEG. This study provides dose prediction models for α5-PAM administration based on EEG biomarkers of depression severity. Given limitations in doing the above in the living human brain, the results and tools we developed will facilitate translation of α5-PAM treatment to clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectroencephalographyReceptors, GABA-AMajor Depressive DisorderHumansComputer SimulationComputational BiologyMachine LearningBrainModels, NeurologicalDepressionSomatostatinDose-Response Relationship, DrugAntidepressive AgentsInterneurons

Substanzen

Receptors, GABA-ASomatostatinAntidepressive Agents

Autor:innen und Institutionen

  • Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Canada.
  • Department of Physiology, University of Toronto, Toronto, Canada.
  • Department of Psychiatry, University of Toronto, Toronto, Canada.
  • Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
  • Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.

ORCID-Profile: Alexandre Guet-McCreight, Etay Hay

Förderung

  • Krembil Foundation
  • Labatt Family Network

Zitieren

APA

Guet-McCreight, A., Mazza, F., Prevot, T. D., Sibille, E., & Hay, E. (2024). Therapeutic dose prediction of α5-GABA receptor modulation from simulated EEG of depression severity. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012693

Vancouver

Guet-McCreight A, Mazza F, Prevot TD, Sibille E, Hay E. Therapeutic dose prediction of α5-GABA receptor modulation from simulated EEG of depression severity. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012693

BibTeX
@article{GuetMcCreight2024,
  author = {Guet-McCreight, Alexandre and Mazza, Frank and Prevot, Thomas D and Sibille, Etienne and Hay, Etay},
  title = {Therapeutic dose prediction of α5-GABA receptor modulation from simulated EEG of depression severity},
  journal = {PLOS Computational Biology},
  year = {2024},
  doi = {10.1371/journal.pcbi.1012693}
}
Kostenlos starten →